Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Edema Secondary”

130 trials

Showing 20 of 130 results

Post-approval studies (Phase 4)Study completedNCT01486238
What this trial is testing

Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study

Who this might be right for
Diabetic Macular Edema
Valley Retina Institute 72
Not applicableStudy completedNCT03452995
What this trial is testing

Lymphodreinage Integrated With Kinesio Tape in TKA Patients

Who this might be right for
TOTAL KNEE ARTHROPLASTYEdema SecondaryPain+1 more
Istituto Ortopedico Rizzoli 99
Testing effectiveness (Phase 2)Study completedNCT00407355
What this trial is testing

Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Peter A Campochiaro, MD 40
Large-scale testing (Phase 3)Study completedNCT04740905
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Macular EdemaBranch Retinal Vein Occlusion
Hoffmann-La Roche 553
Large-scale testing (Phase 3)Study completedNCT00473330
What this trial is testing

Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)

Who this might be right for
Diabetes MellitusMacular Edema
Genentech, Inc. 377
Testing effectiveness (Phase 2)Study completedNCT00900887
What this trial is testing

Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema

Who this might be right for
Diabetic RetinopathyMacular Edema
Hospital Juarez de Mexico 84
Not applicableWithdrawnNCT00375154
What this trial is testing

HERMES STUDY: Study on the Feasibility and Efficiency of Noninvasive Positive-Pressure Ventilation (NPPV) in Prehospital Care

Who this might be right for
ARF Secondary to COPD ExacerbationARF Secondary to Cardiogenic Acute Pulmonary Oedema
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 100
Testing effectiveness (Phase 2)Study completedNCT00804921
What this trial is testing

Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab

Who this might be right for
Macular EdemaDiabetic RetinopathyMacular Degeneration
University of Sao Paulo
Not applicableStudy completedNCT02194803
What this trial is testing

Observation of Treatment Patterns With Lucentis in Approved Indications

Who this might be right for
Neovascular AMD, Visual Impairment Due to DME, Visual Impairment Due to Macular Oedema Secondary to Branch or Central RVO, Visual Impairment Due to CNV
Novartis Pharmaceuticals 5,778
Large-scale testing (Phase 3)Study completedNCT01599650
What this trial is testing

Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Novartis Pharmaceuticals 455
Large-scale testing (Phase 3)Looking for participantsNCT06990399
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

Who this might be right for
Macular Edema Secondary to Inflammation
Kodiak Sciences Inc 150
Large-scale testing (Phase 3)Study completedNCT01976312
What this trial is testing

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Novartis Pharmaceuticals 252
Large-scale testing (Phase 3)Study completedNCT02698566
What this trial is testing

A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)

Who this might be right for
Macular Edema
Genentech, Inc. 35
Testing effectiveness (Phase 2)Study completedNCT01968239
What this trial is testing

Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT

Who this might be right for
Branch Retinal Vein Occlusion
University of Leipzig 27
Testing effectiveness (Phase 2)UnknownNCT01809236
What this trial is testing

Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Chengdu Kanghong Biotech Co., Ltd. 60
Not applicableStudy completedNCT03523494
What this trial is testing

Feasibility of Lymph Edema-induced Reticulation Subtraction Based on Computerized Tomography

Who this might be right for
LymphedemaSecondary LymphedemaCT
Ulsan University Hospital 24
Post-approval studies (Phase 4)Study completedNCT02633852
What this trial is testing

Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema (DME)
Hadassah Medical Organization 48
Large-scale testing (Phase 3)Study completedNCT01535261
What this trial is testing

Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Novartis Pharmaceuticals 357
Early research (Phase 1)Study completedNCT01028248
What this trial is testing

Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion
California Retina Consultants 20
Early research (Phase 1)Study completedNCT00401115
What this trial is testing

Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy

Who this might be right for
Diabetic Macular EdemaDiabetic Retinopathy
Santen Inc. 50
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation